FDA advisory panel recommends a first: multi-cancer blood test
A key advisory committee that reviews medical devices for the Food and Drug Administration recommended the agency approve the first multi-cancer blood test for people 50 and over. Grail, the company that makes the Galleri blood test under review, says it …